Topics

. He can be reached at nsaraceno@mjhlifesciences.com.

Articles

A panel designs a conceptual framework in an effort to limit partiality. 

Mitigating Bias in Healthcare Algorithm Development

Cloud-based service to address verification of saleable returns under the latest DSCSA regulations.
 


ACG Inspection Presents New VRS

Creating a meaningful digital transformation requires pharmaceutical manufacturing companies to incorporate the right technologies, processes, and systems to reach their fullest potential. 

Unlocking Pharma 4.0 Through Edge Computing

Critical factors need to be addressed for pharma stakeholders to realize the full potential of generative artificial intelligence.

Generative Artificial Intelligence Could Transform Healthcare if Challenges Are Addressed

Digital twins allow the industry to integrate sustainable practices and supply chain efficiency solutions while ensuring patient safety.

How Digital Twins Drive Sustainability in Clinical Supply Planning

Findings suggest that participants nationwide who were offered and accessed their online medical record has more than doubled in the past eight years, but racial and ethnic disparities continue. 

Study Digs into Patient Access to Electronic Health Information

Study estimates that up to 20% of the costs for clinical research is associated with the manual transfer and verification of data from the electronic medical record to a data capture system.

AI Can Save Pharma Time and Money, But Concerns Persist With Data Security

New initiative highlights importance of a collaborative approach that allows patients to share their insights and contribute value to studies.

Project Highlights Benefits of Statistical Methodology Research for Patients, Pharma

Michael Wong is an Emeritus Board Member of the Harvard Business School Healthcare Alumni Association.

Stephanie L. Woerner, PhD, director and principal research scientist at the MIT Center for Information Systems Research, discusses the outlook for next year among biopharma firms.

Expert: Digital Transformation is Key Part of Biopharma C-Suite Goals for 2024

A demand-driven methodology for data standardization across multiple streams of acquisition could improve the sharing of real-world data worldwide.

Data & Technology